03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Eltroxin* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | Aspen |
Responsible Party | Glaxo Laboratories Ltd |
Origin | UK |
Manufacturer | Glaxo Laboratories Ltd |
Origin | UK |
ATC | H03AA01 |
Eltroxin* :
Eltroxin* :
Eltroxin* :
Eltroxin* :
Eltroxin* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Eltroxin* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Anginal pain | Not known |
Arrhythmia | Not known |
Arthralgia (Pain joint) (Joint ache) | Not known |
Benign intracranial hypertension | Rare |
Cardiac failure | Not known |
Coma | Not known |
Confusion | Not known |
Craniosynostosis (Premature closure of cranial sutures) | Not known |
Diarrhoea (Diarrhea) | Not known |
Dyspnoea (dyspnea) | Not known |
Excitability | Not known |
Fever | Not known |
Flushing | Not known |
Headache | Not known |
Heat intolerance | Not known |
Hyperpyrexia | Not known |
Hypersensitivity reactions | Not known |
Hypotension | Not known |
Insomnia | Not known |
Jaundice | Not known |
Malaise | Not known |
Menstruation irregular | Not known |
Muscle cramps | Not known |
Muscle weakness | Not known |
Oedema | Not known |
Palpitations | Not known |
Premature epiphyseal closure | Not known |
Pruritus | Not known |
Restlessness | Not known |
Seizures | Not known |
Skin rash | Not known |
Sweating | Not known |
Tachycardia | Not known |
Thyrotoxic crisis (Thyroid crisis) | Not known |
Transient hair loss | Not known |
Vomiting | Not known |
Weight decreased (Weight loss) | Not known |
NB : Products With Same Indication |
Different Units By MoH Code
Eltroxin* MoH 713 :
Form | Tablet |
Package Size | Box of 100 |
Strength | 100µg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 1924/72 |
Submission date | 01/01/1972 |
Registration Year | 1972 |
Archived Date | 2014 |
Price Comparison
You have to register to view this info
Drop File